Similarly to other RPs, RPL23 can act as a tumour suppressor by inhibiting the E3 ubiquitin ligase MDM2, thereby promoting the accumulation of p53 in cells and consequently, p53-dependent cell-cycle arrest and apoptosis [196]. Here, RPL23 is linked to neoplasm.